[The efficacy and safety of rituximab in treatment of Epstein-Barr virus disease post allogeneic hematopoietic stem-cell transplantation].
Xu LP, Liu DH, Liu KY, Zhang CL, Wang FR, Wang JZ, Wang Y, Chen H, Zhang YY, Yan CH, Han W, Chen YH, Zhao T, Zhang XH, Huang XJ.
Xu LP, et al. Among authors: zhang cl, zhang yy, zhang xh.
Zhonghua Nei Ke Za Zhi. 2012 Dec;51(12):966-70.
Zhonghua Nei Ke Za Zhi. 2012.
PMID: 23327959
Chinese.